Close

QS-21, the Gold Standard of immune system activators used in Covid-19 and other vaccines to be presented by CEO Gaston Salinas at BIO CEO & Investor Conference

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

China Unveils Innovative Drugs Policy to Boost Development

The National Health Commission and China's National Healthcare Security...

Ensuring optimal product integrity with pharmaceutical preservation strategies

Preserving the potency of pharmaceutical products is paramount in...

How Stem Cell Therapy Works for the Individual

Stem cell therapy has emerged as one of the...

Tjoapack Expands Injectable Packaging Capabilities Globally

Increased Capabilities in the United States Tjoapack is finishing up...

A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will be the subject of an upcoming presentation at the BIO CEO & Investor Digital Conference, starting February 16.

Gaston Salinas, CEO of Botanical Solution Inc. (BSI) will address the Conference, introducing an innovative approach for the production of QS-21 based on BSI’s proprietary Advanced Botanical Materials. Mr. Salinas will also address additional issues of quality, cost and the sizeable environmental footprint required for traditional sourcing of raw materials, which BSI has solved using plant tissue culture.

QS-21 is traditionally extracted from a tree native to Chile known as the Quillaja saponaria. However, there are regulatory restrictions on deforestation of this tree, and projected demand for QS-21 is in the billions of doses annually.

Mr. Salinas will explain how BSI plans to become the world’s largest supplier of QS-21, among other high value saponins, under GMP conditions, at a low cost, and without any negative environmental impact.

BSI’s R&D platform, manufacturing capabilities and products based on Advanced Botanical Materials have been tested and proven in another multibillion dollar market dominated by fierce competition, large scale operations, challenging price points and limited margins… the agricultural industry. BSI has partnered with Syngenta, a global leader in agrochemicals with $13.5 billion in annualized revenues, to successfully launch its first botanical-based biopesticide, BotriStop®, in the country of Chile for a wide variety of high-value crops. BotriStop plans a roll- out into Peru later this year and its launch is also anticipated for Mexico and the U.S. during late 2022. BSI and Mr. Salinas will also be featured within the ‘Top Innovators’ section at the World Agri-Tech Innovation Summit, March 9 – 10, 2021.

According to Mr. Salinas, “BSI is well- positioned to become the industry’s most reliable and cost-effective supplier of GMP quality QS-21 worldwide.”.

About BSI
BSI is a venture-backed corporation based in Davis, California. The Company has developed a proprietary R&D platform for sustainable and improved production of Advanced Botanical Materials (ABM) that addresses critical and well- known issues related to current production of key traditional botanical raw materials, often obtained under exploitation of natural resources. These issues include the limited supply of materials, geo-political dependence and a sizeable environmental footprint. Additionally, active ingredients derived from traditional botanical raw materials inherit problems of variable consistency, limited production and increasing cost. Botanical Solution’s R&D Platform relies on scalable plant tissue culture techniques that allow scalable and sustainable supply of key botanical materials, geo-political freedom and no environmental footprint.

Latest stories

Related stories

China Unveils Innovative Drugs Policy to Boost Development

The National Health Commission and China's National Healthcare Security...

Ensuring optimal product integrity with pharmaceutical preservation strategies

Preserving the potency of pharmaceutical products is paramount in...

How Stem Cell Therapy Works for the Individual

Stem cell therapy has emerged as one of the...

Tjoapack Expands Injectable Packaging Capabilities Globally

Increased Capabilities in the United States Tjoapack is finishing up...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back